Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Spironolactone plus finasteride reduces hirsutism more effectively.

Hormonal therapies are safe and effective for treating adult women's acne.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Effective treatments for excessive body hair in women include drugs that block androgens, sometimes combined with oral contraceptives.

PCOS treatment should be personalized based on individual symptoms and health goals.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Spironolactone and metformin work similarly for PCOS symptoms, but more research is needed.